We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$90.9M
AUM Growth
+$9.39M
Cap. Flow
+$2.51M
Cap. Flow %
2.76%
Top 10 Hldgs %
11.75%
Holding
179
New
2
Increased
99
Reduced
24
Closed
5

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$777K
2
MTCH icon
Match Group
MTCH
+$705K
3
CLH icon
Clean Harbors
CLH
+$478K
4
ARVN icon
Arvinas
ARVN
+$443K
5
CHEF icon
Chefs' Warehouse
CHEF
+$406K

Sector Composition

Rank Sector Weight
1 Healthcare 31.93%
2 Technology 22.89%
3 Consumer Discretionary 12.96%
4 Industrials 10%
5 Financials 5.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JJSF icon
101
J&J Snack Foods
JJSF
$1.44B
$451K 0.5%
2,848
+650
+30% +$101K
CARG icon
102
CarGurus
CARG
$3.25B
$446K 0.49%
19,689
+1,347
+7% +$25.5K
RCUS icon
103
Arcus Biosciences
RCUS
$3.55B
$444K 0.49%
21,869
+1,368
+7% +$26K
AMED
104
DELISTED
Amedisys
AMED
$444K 0.49%
4,854
+339
+8% +$27.8K
REAL icon
105
The RealReal
REAL
$1.44B
$419K 0.46%
188,731
+38,557
+26% +$52.8K
COHR icon
106
Coherent
COHR
$48.7B
$418K 0.46%
8,203
+658
+9% +$24.4K
WWE
107
DELISTED
World Wrestling Entertainment
WWE
$410K 0.45%
3,784
-3,784
-50% -$391K
ESI icon
108
Element Solutions
ESI
$8.68B
$409K 0.45%
21,321
+1,305
+7% +$24K
IPAR icon
109
Interparfums
IPAR
$4.02B
$409K 0.45%
3,022
BEAM icon
110
Beam Therapeutics
BEAM
$2.73B
$402K 0.44%
12,600
RPAY icon
111
Repay Holdings
RPAY
$328M
$401K 0.44%
51,241
+3,894
+8% +$26.2K
ALGT icon
112
Allegiant Air
ALGT
$2.66B
$393K 0.43%
3,112
-1,300
-29% -$136K
EXAS
113
DELISTED
Exact Sciences
EXAS
$386K 0.42%
4,110
-757
-16% -$59.1K
COMP icon
114
Compass
COMP
$8.56B
$381K 0.42%
108,852
+7,874
+8% +$25.8K
FSLY icon
115
Fastly Inc
FSLY
$3.37B
$380K 0.42%
24,113
+7,008
+41% +$107K
GH icon
116
Guardant Health
GH
$20.2B
$373K 0.41%
10,422
+1,059
+11% +$30.4K
GDYN icon
117
Grid Dynamics Holdings
GDYN
$590M
$372K 0.41%
40,242
+2,203
+6% +$22.1K
FORR icon
118
Forrester Research
FORR
$189M
$368K 0.4%
12,646
+1,666
+15% +$49.5K
TRUP icon
119
Trupanion
TRUP
$1.07B
$352K 0.39%
17,900
+9,068
+103% +$256K
TXG icon
120
10x Genomics
TXG
$6.28B
$351K 0.39%
6,285
-370
-6% -$20K
ENOV icon
121
Enovis
ENOV
$1.69B
$349K 0.38%
5,446
+466
+9% +$26.5K
FLWS icon
122
1-800-Flowers.com
FLWS
$246M
$339K 0.37%
43,428
+3,333
+8% +$30.6K
DNA icon
123
Ginkgo Bioworks
DNA
$528M
$339K 0.37%
4,552
NMRK icon
124
Newmark Group
NMRK
$2.68B
$337K 0.37%
54,196
LBRT icon
125
Liberty Energy
LBRT
$2.93B
$330K 0.36%
+24,650
New +$319K

Similar funds

Capital Impact Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Capital Impact Advisors held 179 positions worth $90.9M, up 12% from $81.5M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 3.9%. Capital Impact Advisors opened 2 new positions and exited 5, leaving the 179-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Capital Impact Advisors's largest Q2 2023 buy was United Therapeutics: 3,507 shares worth $774K.
  • Capital Impact Advisors added most to Match Group in Q2 2023, an estimated $705K increase.
  • Capital Impact Advisors's biggest Q2 2023 reduction was Super Micro Computer, cutting an estimated $760K.
  • Capital Impact Advisors fully exited Kinder Morgan in Q2 2023, selling an estimated $521K.
  • Capital Impact Advisors's ten largest holdings make up 12% of its $90.9M portfolio in Q2 2023.
  • Capital Impact Advisors opened 2 new positions and closed 5 in Q2 2023.
  • Capital Impact Advisors's portfolio value rose 12% quarter-over-quarter to $90.9M.

Based on Capital Impact Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.